Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 08/26/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–08/25/2026 Record Record Date Vuga Group Change Status Recency Days Public Significance Score Clinical Follow-up of Pregnant Subjects Undergoing NIPT 10/20/2020 OBSERVATIONAL unchanged 2,136.85 0 IORT-Breast at Medical Center Navicent Health 10/20/2020 OBSERVATIONAL unchanged 2,136.85 0 Factors Influencing Fertility or Pregnancy Health 10/22/2020 OBSERVATIONAL unchanged 2,134.85 0 Impact of Tamsulosin on Post-Operative Urinary Retention Following Pelvic Reconstructive Surgery 10/22/2020 INTERVENTIONAL unchanged 2,134.85 0 The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA 10/22/2020 OBSERVATIONAL unchanged 2,134.85 0 The MASTER Study (MAmmary Cancer STatin ER Positive Study) 10/23/2020 INTERVENTIONAL unchanged 2,133.85 0 Addition of Pembrolizumab to the Standard of Care Chemotherapy in Patient With SCCOHT 10/26/2020 INTERVENTIONAL unchanged 2,130.85 0 Registry Study of Pregnancy and Breast Cancer 10/27/2020 OBSERVATIONAL unchanged 2,129.85 0 When to INDuce for OverWeight? (WINDOW) 10/27/2020 INTERVENTIONAL unchanged 2,129.85 0 Prediction of Recurrence Among Low Risk Endometrial Cancer Patients 10/27/2020 OBSERVATIONAL unchanged 2,129.85 0 Study of Carboplatin and Mirvetuximab Soravtansine in First-Line Treatment of Patients Receiving Neoadjuvant Chemotherapy With Advanced-Stage Ovarian, Fallopian Tube or Primary Peritoneal Cancer 10/28/2020 INTERVENTIONAL unchanged 2,128.85 0 Single Cell Immune and Non-immune Correlates of Response to Neoadjuvant Abemaciclib 11/03/2020 INTERVENTIONAL unchanged 2,122.85 0 Immunological Mechanisms of Rejection in Uterine Transplantation 11/04/2020 INTERVENTIONAL unchanged 2,121.85 0 Exercise and Cognitive (Brain) Function in Breast Cancer Patients Getting Chemotherapy After Breast Surgery 11/04/2020 OBSERVATIONAL unchanged 2,121.85 0 Biomarkers of Endometrial Receptivity 11/06/2020 INTERVENTIONAL unchanged 2,119.85 0 Yoga Therapy During Chemotherapy and Radiation Treatment for the Improvement of Physical and Emotional Well-Being in Patients With Stage IB2-IIIB Cervical Cancer 11/10/2020 INTERVENTIONAL unchanged 2,115.85 0 Pre-operative Exercise During Neoadjuvant Chemotherapy in Patients With Breast Cancer 11/10/2020 INTERVENTIONAL unchanged 2,115.85 0 A Study of Avutometinib (VS-6766) v. Avutometinib (VS-6766) + Defactinib in Recurrent Low-Grade Serous Ovarian Cancer With and Without a KRAS Mutation 11/12/2020 INTERVENTIONAL unchanged 2,113.85 0 Mindfulness & Mechanisms Study 11/12/2020 INTERVENTIONAL unchanged 2,113.85 0 American Cranberries to Prevent UTIs in Susceptible Women 11/12/2020 INTERVENTIONAL unchanged 2,113.85 0 Research on the Heterogeneity of Taiwanese Breast Cancer Patients by Next Generation Sequencing (NGS) Tools 11/12/2020 OBSERVATIONAL unchanged 2,113.85 0 Diagnostic, Therapeutic and Reproductive Aspects of Patients With Mullerian Anomalies 11/13/2020 OBSERVATIONAL unchanged 2,112.85 0 Alopecia Prevention Scalp Cooling in Chinese Breast Cancer Patients 11/16/2020 INTERVENTIONAL unchanged 2,109.85 0 Maternal Betaine Supplementation During Breastfeeding 11/18/2020 INTERVENTIONAL unchanged 2,107.85 0 Testing the Addition of Abemaciclib to Olaparib for Women With Recurrent Ovarian Cancer 11/18/2020 INTERVENTIONAL unchanged 2,107.85 0 Health Disparities on the Labor Floor 11/18/2020 OBSERVATIONAL unchanged 2,107.85 0 Pelvic Floor Dysfunction and Quality of Life in Uterine Cancer Survivors 11/18/2020 OBSERVATIONAL unchanged 2,107.85 0 Study of Pembrolizumab (MK-3475) in Combination With Adjuvant Chemotherapy With or Without Radiotherapy in Participants With Newly Diagnosed Endometrial Cancer After Surgery With Curative Intent (MK-3475-B21 / KEYNOTE-B21 / ENGOT-en11 / GOG-3053) 11/18/2020 INTERVENTIONAL unchanged 2,107.85 0 Refining Local-Regional Therapy for IBC 11/19/2020 INTERVENTIONAL unchanged 2,106.85 0 Surgical Intervention for Refractory Granulomatous Lobular Mastitis 11/20/2020 INTERVENTIONAL unchanged 2,105.85 0 Identification of Genetic Determinants for Treatment Resistance/Sensitivity and/or Toxicity in Adjuvant Setting for HER2 Positive Breast Cancer 11/20/2020 OBSERVATIONAL unchanged 2,105.85 0 The PreQ-20 TRIAL, a Prospective Cohort Study of Patients Undergoing Prepectoral Breast Reconstruction 11/24/2020 INTERVENTIONAL unchanged 2,101.85 0 Comparison of Hemostatic Agent to Suture in Terms of Hemostatic Function and Preservation of Ovarian Function 11/24/2020 INTERVENTIONAL unchanged 2,101.85 0 WoO: Window of Opportunity Trial of Olaparib and Durvalumab in Histologically Proven EOC 11/25/2020 INTERVENTIONAL unchanged 2,100.85 0 Fulvestrant or Capecitabine Combined With Pyrotinib in HR+/HER2+ Metastatic Breast Cancer 11/30/2020 INTERVENTIONAL unchanged 2,095.85 0 Application of Chinese Herbal Complementary and Alternative Medicine (CAM) to Improve Human Health and to Further Botanical and Horticultural Sciences 12/02/2020 INTERVENTIONAL unchanged 2,093.85 0 Effect of Vitamin D on Ovulation Rate in Women With Polycystic Ovary Syndrome 12/03/2020 INTERVENTIONAL unchanged 2,092.85 0 GYNecological Cancers Treated with NETrin MAbs in Combination with Chemotherapy and /or Pembrolizumab 12/03/2020 INTERVENTIONAL unchanged 2,092.85 0 Preventing Chemotherapy-induced Peripheral Neuropathy Using PRESIONA Exercise Program 12/03/2020 INTERVENTIONAL unchanged 2,092.85 0 Naprapathy Training for Postpartum DRAM Prevention 12/03/2020 INTERVENTIONAL unchanged 2,092.85 0 Omic Technologies to Track Resistance to Palbociclib in Metastatic Breast Cancer 12/04/2020 INTERVENTIONAL unchanged 2,091.85 0 To Identify Primary Resistance to CDK4/6 Inhibitors in Breast Cancer 12/09/2020 OBSERVATIONAL unchanged 2,086.85 0 Congenital Uterine Anomalies: Identifying Cancer Associations and Genetic and Environmental Factors to Improve Clinical Care 12/09/2020 OBSERVATIONAL unchanged 2,086.85 0 BREAST ADM Trial for Alloplastic Breast Reconstruction 12/10/2020 INTERVENTIONAL unchanged 2,085.85 0 Mueller Polarimetric Colposcopy for High-performance Detection of Cervical Changes During Pregnancy 12/10/2020 INTERVENTIONAL unchanged 2,085.85 0 Rectosigmoid Resection vs Seromuscular Tumor Shaving in Ovarian Cancer Surgery 12/11/2020 INTERVENTIONAL unchanged 2,084.85 0 Nomogram to Predict Breast Cancer Related Lymphedema 12/14/2020 INTERVENTIONAL unchanged 2,081.85 0 Impact of Neoadjuvant Hormonal Therapy on the Surgical Management of Extensive Ductal Carcinomas in Situ 12/14/2020 INTERVENTIONAL unchanged 2,081.85 0 Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment 12/14/2020 INTERVENTIONAL unchanged 2,081.85 0 Accelerated Partial Breast Irradiation Versus Standard or Hypofractionated Whole-Breast Irradiation, in Early Breast Cancer, After Breast-conserving Surgery 12/17/2020 INTERVENTIONAL unchanged 2,078.85 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 08/26/2026 · upstream last modified 08/26/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Public Significance Score using the documented compute method. · methodology